Literature DB >> 6215377

Evaluation of piperacillin sodium in the treatment of infections in immune compromised patients.

D A Kelly, J J Fennelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6215377     DOI： 10.1007/bf02940191

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  4 in total

1.  Piperacillin: in vitro evaluation.

Authors:  G P Bodey; B Le Blanc
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

2.  In vitro and in vivo activity of piperacillin, a new broad-spectrum semisynthetic penicillin.

Authors:  N A Kuck; G S Redin
Journal:  J Antibiot (Tokyo)       Date:  1978-11       Impact factor: 2.649

3.  Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.

Authors:  G R Monif; P R Clark; J J Shuster; H Baer
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.

Authors:  G W White; J B Malow; V M Zimelis; H Pahlavanzadeh; A P Panwalker; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.